secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001683168-24-003104
Event type: regulatory
Sentiment:  neutral
Materiality: 0.25
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma appoints Bush & Associates as new auditor, eff. May 7, 2024
------------------------------------------------------------------------------

- Bush & Associates CPA LLC engaged as independent registered public accounting firm as of May 7, 2024.
- Decision approved by unanimous board consent; no prior consultations with new auditor reported.
- No disagreements or reportable events in the past two fiscal years or subsequent interim period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824003104/0001683168-24-003104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824003104/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-003104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer